tvm-capital.ae
Portfolio - TVM Capital Healthcare Partners
http://www.tvm-capital.ae/portfolio
Skip to primary navigation. TVM Capital Healthcare Partners. Advancing healthcare for a better future. 8220;We develop healthcare investment concepts based on market research, invest in highly attractive specialist healthcare providers led by capable and dynamic management teams and support the successful expansion and growth of these businesses.”. Cambridge Medical & Rehabilitation Center. Manzil Health Care Services. ProVita International Medical Center. Middot; Privacy Policy. TVM Capital Life Science.
cb-one-holding.com
News
http://www.cb-one-holding.com/News.html
Leon-nanodrugs GmbH raises EUR 18.5 million in Series A financing. TVM Capital Life Science leads international syndicate of investors - an additional EUR 3 million investment is expected later in 2015. Munich, 27 July 2015. Cornelia Beier, Managing Director. About TVM Capital Life Science. TVM Capital Life Science is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 30-years of transatlantic investment track record and in ex...
cboneholding.wordpress.com
Juli | 2015 | CB one Holding I Vienna
https://cboneholding.wordpress.com/2015/07
CB one Holding I Vienna. Lifes Science – Digital Health – Health 2.0 – www.cb-one-holding.at. CoreRx partners with leon-nanodrugs to offer nano-based MicroJet Reactor (MJR ) drug formulations. We thePeople – UN Global Goals. Farewell to competitiveness companies need a new operating system Marc Stoffel TEDxZurich. New Homepage leon-nanodrugs on occasion of BIO Europe 2015. Leon-nanodrugs GmbH Raises EUR 18.5 Million In Series A Financing. We thePeople –…. Zu We thePeople – UN Global…. CB one Holding I Vi...
cboneholding.wordpress.com
leon-nanodrugs GmbH Raises EUR 18.5 Million In Series A Financing | CB one Holding I Vienna
https://cboneholding.wordpress.com/2015/07/27/leon-nanodrugs-gmbh-raises-eur-18-5-million-in-series-a-financing
CB one Holding I Vienna. Lifes Science – Digital Health – Health 2.0 – www.cb-one-holding.at. CoreRx partners with leon-nanodrugs to offer nano-based MicroJet Reactor (MJR ) drug formulations. We thePeople – UN Global Goals. Farewell to competitiveness companies need a new operating system Marc Stoffel TEDxZurich. New Homepage leon-nanodrugs on occasion of BIO Europe 2015. Leon-nanodrugs GmbH Raises EUR 18.5 Million In Series A Financing. We thePeople –…. Zu We thePeople – UN Global…. Benachrichtigung be...
leonnanodrugs.wordpress.com
corneliabeier |
https://leonnanodrugs.wordpress.com/author/connybeier
Creating new values for established drugs! A passionate entrepreneur in health and life sciences, writer, photographer, philanthropist and curious seeker for a meaningful and sustainable life. New Homepage on occasion of BIO Europe 2015. Leon-nanodrugs GmbH Starts U.S. Operations and Appoints Industry Veteran Theron (Ted) Odlaug as Chief Executive Officer – Company expands global footprint as a result of recently announced Series A financing –. Cornelia Beier, CCO. Theon E. Odlaug, CEO. Leon-nanodrugs Gm...
cboneholding.wordpress.com
corneliabeier | CB one Holding I Vienna
https://cboneholding.wordpress.com/author/connybeier
CB one Holding I Vienna. Lifes Science – Digital Health – Health 2.0 – www.cb-one-holding.at. CoreRx partners with leon-nanodrugs to offer nano-based MicroJet Reactor (MJR ) drug formulations. We thePeople – UN Global Goals. Farewell to competitiveness companies need a new operating system Marc Stoffel TEDxZurich. New Homepage leon-nanodrugs on occasion of BIO Europe 2015. Leon-nanodrugs GmbH Raises EUR 18.5 Million In Series A Financing. We thePeople –…. Zu We thePeople – UN Global…. It is estimated tha...
tvm-lifescience.com
Portfolio - TVM Capital Life Science Venture Capital
http://www.tvm-lifescience.com/portfolio
Skip to primary navigation. TVM Capital Life Science Venture Capital. Investing in Life Science Innovation. Acer Therapeutics, Inc. Argos Therapeutics, Inc. Concert Pharmaceuticals, Inc. Direvo Industrial Biotechnology GmbH. Investment: 2005, exit 2015. Modulate Therapeutics, Inc. Newron Pharmaceuticals S.p.A. Investment: 2005, IPO 2006. Investment: 2007 IPO 2014. Proteon Therapeutics, Inc. Investment: 2006, IPO 2014. Rapid Micro Biosystems, Inc. Sirna Therapeutics, Inc. Middot; Privacy Policy.
tvm-lifescience.com
Argos Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 ADAPT Clinical Trial of AGS-003 - TVM Capital Life Science Venture Capital
http://www.tvm-lifescience.com/argos-therapeutics-announces-completion-of-patient-enrollment-in-pivotal-phase-3-adapt-clinical-trial-of-ags-003
Skip to primary navigation. TVM Capital Life Science Venture Capital. Investing in Life Science Innovation. July 17, 2015. Argos Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 ADAPT Clinical Trial of AGS-003. Fully Personalized Immunotherapy is Being Evaluated in Combination With Standard Targeted Therapy for the Treatment of Newly Diagnosed Metastatic Renal Cell Carcinoma. About the Arcelis Technology Platform. Source: Argos Therapeutics, Inc. Middot; Privacy Policy.
tvm-capital.ae
Partners for Excellence - TVM Capital Healthcare Partners
http://www.tvm-capital.ae/performance-partners
Skip to primary navigation. TVM Capital Healthcare Partners. Advancing healthcare for a better future. 8220;We invest in the growth of pioneering companies, supported by our partnerships with strong international healthcare institutions.”. TVM Capital Healthcare Partners and JCI, a non-profit healthcare accreditation organization, entered a strategic partnership to help increase awareness and efforts related to quality and patient safety across the continuum of care in the Middle East. Under the agre...
SOCIAL ENGAGEMENT